Novel combination approaches with targeted agents in frontline chronic lymphocytic leukemia

Lipsky, A. H., & Lamanna, N. (2022). Novel combination approaches with targeted agents in frontline chronic lymphocytic leukemia. Cancer, 129(1), 18–31. Portico. https://doi.org/10.1002/cncr.34510
Authors:
Andrew H Lipsky
Nicole Lamanna
Affiliated Authors:
Andrew H Lipsky
Nicole Lamanna
Columbia Affiliation:
Subjects:
Leukemia, Lymphocytic, Chronic, B-Cell (MeSH)
Antineoplastic Agents (MeSH)
Author Keywords:
bcl2 inhibitors
bruton tyrosine kinase (btk)
bruton tyrosine kinase inhibitors
chronic lymphocytic leukemia
targeted combinations
targeted therapy
elink
Publication Type:
Article
Unique ID:
10.1002/cncr.34510
PMID:
36326285
DOI:
10.1002/cncr.34510
Journal:
Cancer
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: